![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JE Piletz, H Zhu and DN Chikkala
Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, USA.
To identify selective compounds for nonadrenergic I1-imidazoline receptors (I1), the affinities of 22 ligands for [125I]p-iodoclonidine binding have been compared at human platelet I1-imidazoline binding sites (analyzed under norepinephrine mask of alpha-2 AR) and at human alpha-2A, alpha-2B and alpha-2C adrenoceptors stably expressed on transfected Chinese hamster ovary cells. Competition curves at the platelet I1-imidazoline binding site were biphasic for most compounds. Only tizanidine and BDF,6143 displayed monophasic I1 competition curves. Agmatine, an endogenous neurotransmitter candidate for the I1- imidazoline receptor, was identified as the most selective agent for a subcomponent of platelet I1 sites. The affinity of agmatine at the high affinity component of platelet I1 sites was 1400-fold selective over alpha-2A adrenoceptors, 5000-fold selective over alpha-2B adrenoceptors and 800-fold selective over alpha-2C adrenoceptors. Moxonidine and tizanidine also displayed selectivities for a high affinity component of the platelet I1 binding sites over alpha-2 adrenoceptors. Naphazoline was the most selective compound for the high affinity state of the alpha-2A adrenoceptor, displaying 7-, 23- and 9-fold higher affinity than alpha-2B, alpha-2C and platelet I1-midazoline binding sites, respectively. No single selective compound was identified for the alpha-2B adrenoceptor. Norepinephrine displayed, respectively, 18- and 31-fold selectivity for the high affinity state of the alpha-2C adrenoceptor as compared to alpha-2A- or alpha-2B adrenoceptors, and was > 100,000- fold selective over platelet I1-imidazoline sites. Thus, human alpha-2 adrenoceptors and the platelet I1-imidazoline binding site can be clearly discriminated based on their affinities for certain compounds.
This article has been cited by other articles:
|
|
 |
|
  M. Tanabe, Y. Kino, M. Honda, and H. Ono Presynaptic I1-Imidazoline Receptors Reduce GABAergic Synaptic Transmission in Striatal Medium Spiny Neurons J. Neurosci., February 8, 2006; 26(6): 1795 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hermann, T. Schlereth, T. Vogt, and F. Birklein Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skin J Appl Physiol, December 1, 2005; 99(6): 2266 - 2270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kagawa, Y. Hayashi, I. Itoh, M. Iwasaki, K. Takada, T. Kamibayashi, A. Yamatodani, and T. Mashimo Identification of the Central Imidazoline Receptor Subtype Involved in Modulation of Halothane-Epinephrine Arrhythmias in Rats Anesth. Analg., December 1, 2005; 101(6): 1689 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Greney, D. Urosevic, S. Schann, L. Dupuy, V. Bruban, J.-D. Ehrhardt, P. Bousquet, and M. Dontenwill [125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1 Imidazoline Receptors Mol. Pharmacol., July 1, 2002; 62(1): 181 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Greney, P. Ronde, C. Magnier, F. Maranca, C. Rascente, W. Quaglia, M. Giannella, M. Pigini, L. Brasili, C. Lugnier, et al. Coupling of I1 Imidazoline Receptors to the cAMP Pathway: Studies with a Highly Selective Ligand, Benazoline Mol. Pharmacol., June 1, 2000; 57(6): 1142 - 1151. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Arimitsu, M. Mitsui-Saito, K. Sato, H. Ozaki, Y. Koga, and H. Karaki Mechanism of Relaxant Effect of Clonidine in Isolated Bovine Tracheal Smooth Muscle J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 681 - 687. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
